Veracyte | VCYT - Umlaufvermögen





Umlaufvermögen Veränderung Datum
Agenus USD 95.28M 38.15M 2026-03
Agilent USD 4.76B 148M 2026-03
Anika Therapeutics USD 93.56M 9.8M 2026-03
Arrowhead Research USD 1.84B 665.36M 2026-03
Bruker USD 2.1B 108.9M 2026-03
Heron Therapeutics USD 228.98M 9.08M 2026-03
Illumina USD 2.74B 551M 2026-03
Intrexon USD 23.72M 45.04M 2024-06
Karyopharm Therapeutics USD 103.15M 13.4M 2025-12
Laboratory Of America USD 4.56B 538.3M 2026-03
Ligand Pharmaceuticals USD 865.42M 33.14M 2026-03
Myriad Genetics USD 312.8M 19.8M 2026-03
Rigel Pharmaceuticals USD 214.93M 39.53M 2025-09
Roche Holding CHF 38.73B 3.03B 2025-12
Sangamo BioSciences USD 49.89M 12.3M 2025-06
Siemens EUR 68.95B 1.04B 2026-03
Sonic Healthcare AUD 2.3B 52.76M 2024-12
Thermo Fisher Scientific USD 22.32B 6.39B 2026-03
Veracyte USD 522.17M 33.8M 2026-03
Waters USD 3.72B 1.73B 2026-03